FibroBiologics Inc. Commo...
(FBLG)
undefined
undefined%
At close: undefined
2.22
1.37%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | - | - | - |
Cost of Revenue | 437.00K | 94.00K | - | - |
Gross Profit | -437.00K | -94.00K | - | - |
Operating Income | -8.89M | -4.47M | -1.58M | -1.17M |
Interest Income | - | - | - | - |
Pretax Income | -16.48M | -5.12M | -1.58M | -1.17M |
Net Income | -16.48M | -5.12M | -1.58M | -1.17M |
Selling & General & Admin | 6.52M | 3.23M | 1.06M | 500.00K |
Research & Development | 2.37M | 1.15M | 521.00K | 669.00K |
Other Expenses | - | - | - | - |
Operating Expenses | 8.89M | 4.37M | 1.58M | 1.17M |
Interest Expense | 147.00K | 654.00K | 4.00K | - |
Selling & Marketing Expenses | 685.00K | -94.00K | - | - |
Cost & Expenses | 8.89M | 4.47M | 1.58M | 1.17M |
Income Tax | - | - | - | - |
Shares Outstanding (Basic) | 32.49M | 32.49M | 32.49M | 8.75M |
Shares Outstanding (Diluted) | 28.23M | 32.49M | 32.49M | 8.75M |
EPS (Basic) | -0.59 | -0.16 | -0.05 | -0.13 |
EPS (Diluted) | -0.68 | -0.16 | -0.05 | -0.13 |
EBITDA | -15.90M | -4.37M | -1.58M | - |
Depreciation & Amortization | 437.00K | 94.00K | - | 1.17M |